MSA
EW icon

Marino Stram & Associates’s Edwards Lifesciences EW Stock Holding History

Marino Stram & Associates’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,920
Closed -$122K – 234
2019
Q1 		$122K Buy
1,920
+63
+3% +$3.6K 0.09% 103
2018
Q4 		$95K Sell
1,857
-243
-12% -$12.3K 0.08% 113
2018
Q3 		$122K Hold
2,100
– – 0.1% 108
2018
Q2 		$102K Sell
2,100
-1,800
-46% -$84K 0.09% 120
2018
Q1 		$181K Hold
3,900
– – 0.17% 84
2017
Q4 		$147K Buy
+3,900
New +$143K 0.14% 92

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Marino Stram & Associates's EW Position: Q2 2019 in Review

Marino Stram & Associates sold out of Edwards Lifesciences (EW) in Q2 2019, closing a stake of 1,920 shares — an estimated $122K sold.

Marino Stram & Associates first reported a position in EW in Q4 2017 and held it in 6 quarters. The position peaked at $181K in Q1 2018. 921 funds tracked by Wall St. Rank hold EW as of Q2 2019.

  • Marino Stram & Associates reported no remaining Edwards Lifesciences position as of Q2 2019 after selling out during the quarter.
  • Marino Stram & Associates sold 1,920 Edwards Lifesciences shares in Q2 2019, an estimated $122K.
  • Marino Stram & Associates first reported a position in Edwards Lifesciences in Q4 2017 and held it in 6 quarters.
  • Marino Stram & Associates's Edwards Lifesciences position peaked at $181K in Q1 2018.
  • 921 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2019.

Based on Marino Stram & Associates's 13F filing for Q2 2019, filed 19 Jul 2019.